Ricerca and Fulcrum Pharma in Pact

The collaboration between the two pharma companies is expected to create a streamlined and efficient process to move a candidate from development to clinical evaluation.

CRO Ricerca Biosciences has entered a cooperation agreement with Fulcrum Pharma, an Aptiv Solutions company, to provide value-added capabilities to biopharma companies by creating a streamlined and efficient process to move a drug candidate from development to the clinic.

The collaboration will leverage Ricerca’s comprehensive preclinical services from early discovery medicinal chemistry, compound screening, profiling and lead optimization through full drug safety, metabolism and efficacy development support, as well as clinical supply and commercial API production. Fulcrum Pharma provides strategic and operational regulatory support to assist clients with regulatory submissions.

"The Fulcrum Pharma collaboration is an attractive and exci